HOVASHAFI LIMITED
ActiveKey figures
Like most small UK companies, HOVASHAFI LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Sector comparison
SIC 86210Where the company stands among the 22,560 active companies whose first SIC code is 86210 (General medical practice activities).
- MSI REPRODUCTIVE CHOICES£258.8m
- SPAMEDICA LTD£252.2m
- INTERNATIONAL SOS ASSISTANCE UK LIMITED£147.6m
- INHEALTH LIMITED£141.5m
- TIC MEDICAL GROUP HOLDINGS LIMITED£117.3m
- AMBULATORY SURGERY INTERNATIONAL LTD£109m
- COMMUNITY HEALTH AND EYECARE LIMITED£65.6m
- IMMUNODIAGNOSTIC SYSTEMS HOLDINGS LIMITED£51.4m
- VERISK RISK RATING LIMITED£41.7m
- AT MEDICS LIMITED£31.6m
Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 22,560. The line on each bar marks the median.
Summary: HOVASHAFI LIMITED
What kind of company is it?
HOVASHAFI LIMITED is a private limited company registered with Companies House under company number 12565489. It was incorporated on 21 Apr 2020. Its status is active. The registered office is in Scunthorpe (DN15). Its nature of business (SIC 2007) is general medical practice activities (86210).
How is the company doing financially?
The latest accounts in the database are for 2024/25 (period ending 30 Apr 2025); the company files small company accounts (filleted). Net assets were £56,579, up 33.8% on the previous year. Cash at bank and in hand was £12,146. The company had an average of 0 employees. Figures are available for 5 financial years (2020/21–2024/25).
How does it compare with similar companies?
Compared with 22,560 active companies whose first SIC code is 86210: By net assets it ranks higher than 66% of them (median £19,151). By cash it ranks lower than 67% of them (median £33,759). By number of employees it ranks lower than 65% of them (median 1). It is older than 56% of them (median age 5.3 years).
Who runs and controls the company?
The company has 1 current director. One person with significant control is registered.
When are its next filings due?
The next accounts are due by 29 Jan 2027. The next confirmation statement is due by 20 Oct 2027.
Filed accounts2020/21–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | — | — | 52,984 | 17,286 | 12,146 |
| Total assets | 9,161 | 39,294 | — | — | — |
| Total liabilities | 7,921 | 19,607 | 20,805 | 25,002 | 44,433 |
| Net assets / total equity | 1,240 | 19,687 | 32,179 | 42,288 | 56,579 |
| Average number of employees | 3 | 3 | 2 | 2 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
History
16 events- Financial year 2024/25 endedAccounts: net assets £56.6k, 0 employees
- Financial year 2023/24 endedAccounts: net assets £42.3k, 2 employees
- Financial year 2022/23 endedAccounts: net assets £32.2k, 2 employees
- Nida ADNAN resignedDirector
- Mrs Nida Adnan ceased to be a person with significant control
- Kamran MUZAFFAR resignedDirector
- Financial year 2021/22 endedAccounts: net assets £19.7k, 3 employees
- Mr Kamran Muzaffar ceased to be a person with significant control
Earlier events (8)
- Financial year 2020/21 endedAccounts: net assets £1,240, 3 employees
- Mrs Nida Adnan registered as a person with significant control
- Mr Kamran Muzaffar registered as a person with significant control
- Kamran MUZAFFAR appointedDirector
- Adnan MUZAFFAR appointedDirector
- Nida ADNAN appointedDirector
- Dr Adnan Muzaffar registered as a person with significant control
- Company incorporatedPrivate limited company
Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current and former persons with significant control, and the end of each financial year with figures in the database.